Effects of microRNA‑338‑3p on morphine‑induced apoptosis and its underlying mechanisms

Weng,Hong‑Liang; Wang,Ming‑Jing

doi:10.3892/mmr.2016.5506

Effects of microRNA‑338‑3p on morphine‑induced apoptosis and its underlying mechanisms

Authors:
- Hong‑Liang Weng
- Ming‑Jing Wang
View Affiliations

Affiliations: Department of Anesthesia, Linyi Yishui Central Hospital, Linyi, Shandong 276400, P.R. China, Department of Clinical Laboratory, Linyi Yishui Central Hospital, Linyi, Shandong 276400, P.R. China
Published online on: July 12, 2016 https://doi.org/10.3892/mmr.2016.5506
Pages: 2085-2092

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the effects of microRNA-338-3p (miR-338-3p) on morphine (MP)-induced apoptosis, and its underlying mechanisms. Freshly‑isolated mouse peritoneal macrophages were cultured in vitro and treated with MP following transfection with miR‑338‑3p mimic, inhibitor or controls. miR‑338‑3p expression levels increased significantly following MP treatment (P<0.01). This increase was enhanced following transfection with miR‑338‑3p mimic (P<0.05) and abrogated following transfection with miR‑338‑3p inhibitor (P<0.05). The apoptotic rate increased significantly in groups treated with MP (P<0.05); however, this increase was abrogated by transfection with miR‑338‑3p inhibitor (P<0.05). Bioinformatics software predicted that sex determining region Y‑box 4 (SOX4) was the target gene of miR‑338‑3p and this was verified using a dual‑luciferase reporter gene system. SOX4 mRNA and protein expression levels decreased significantly following MP treatment (P<0.05); however, this decrease was abrogated following transfection with miR‑338‑3p inhibitor (P<0.05). Caspase‑3 protein expression levels increased markedly following MP treatment (P<0.05); however, this increase was inhibited by transfection with miR‑338‑3p inhibitor (P<0.05). Therefore, decreased expression of miR‑338‑3p may suppress MP‑induced apoptosis, potentially via the upregulation of SOX4 expression and the caspase‑3‑dependent apoptotic signaling pathway.

View Figures

View References

1	Farazi TA, Hoell JI, Morozov P and Tuschl T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013. View Article : Google Scholar : PubMed/NCBI
2	Yu B, Qian T, Wang Y, Zhou S, Ding G, Ding F and Gu X: miR-182 inhibits Schwann cell proliferation and migration by targeting FGF9 and NTM, respectively at an early stage following sciatic nerve injury. Nucleic Acids Res. 40:10356–10365. 2012. View Article : Google Scholar : PubMed/NCBI
3	Rahmann S, Martin M, Schulte JH, Köster J, Marschall T and Schramm A: Identifying transcriptional miRNA biomarkers by integrating high-throughput sequencing and real-time PCR data. Methods. 59:154–163. 2013. View Article : Google Scholar
4	Gurtan AM and Sharp PA: The role of miRNAs in regulating gene expression networks. J Mol Biol. 425:3582–3600. 2013. View Article : Google Scholar : PubMed/NCBI
5	Kong X, Xu X, Yan Y, Guo F, Li J, Hu Y, Zhou H and Xun Q: Estrogen regulates the tumour suppressor MiRNA-30c and its target gene, MTA-1, in endometrial cancer. PLoS One. 9:e908102014. View Article : Google Scholar : PubMed/NCBI
6	Fiori E, Babicola L, Andolina D, Coassin A, Pascucci T, Patella L, Han YC, Ventura A and Ventura R: Neurobehavioral alterations in a genetic murine model of Feingold Syndrome 2. Behav Genet. 45:547–559. 2015. View Article : Google Scholar : PubMed/NCBI
7	Poliseno L, Salmena L, Zhang J, Carver B, Haveman WJ and Pandolfi PP: A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature. 465:1033–1038. 2010. View Article : Google Scholar : PubMed/NCBI
8	Sayed D and Abdellatif M: MicroRNAs in development and disease. Physiol Rev. 91:827–887. 2011. View Article : Google Scholar : PubMed/NCBI
9	Takahashi RU, Miyazaki H and Ochiya T: The Roles of MicroRNAs in Breast Cancer. Cancers (Basel). 7:598–616. 2015. View Article : Google Scholar
10	Dahiya N and Atreya CD: MicroRNAs and Major Blood-borne Infectious Viral Diseases. Microrna. 2:212–218. 2014. View Article : Google Scholar : PubMed/NCBI
11	Bimonte S, Barbieri A, Rea D, Palma G, Luciano A, Cuomo A, Arra C and Izzo F: Morphine promotes tumor angiogenesis and increases breast cancer progression. Biomed Res Int. 2015:1615082015. View Article : Google Scholar : PubMed/NCBI
12	Nomura Y, Kawaraguchi Y, Sugimoto H, Furuya H and Kawaguchi M: Effects of morphine and fentanyl on 5-fluorouracil sensitivity in human colon cancer HCT116 cells. J Anesth. 28:298–301. 2014. View Article : Google Scholar
13	Gonzalez-Nunez V, Noriega-Prieto JA and Rodriguez RE: Morphine modulates cell proliferation through mir133b &mir128 in the neuroblastoma SH-SY5Y cell line. Biochim Biophys Acta. 1842:566–572. 2014. View Article : Google Scholar : PubMed/NCBI
14	Zheng H, Zeng Y, Chu J, Kam AY, Loh HH and Law PY: Modulations of NeuroD activity contribute to the differential effects of morphine and fentanyl on dendritic spine stability. J Neurosci. 30:8102–8110. 2010. View Article : Google Scholar : PubMed/NCBI
15	Sanchez-Simon FM, Zhang XX, Loh HH, Law PY and Rodriguez RE: Morphine regulates dopaminergic neuron differentiation via miR-133b. Mol Pharmacol. 78:935–942. 2010. View Article : Google Scholar : PubMed/NCBI
16	Nadeau SE: Opioids for chronic noncancer pain: To prescribe or not to prescribe-What is the question? Neurology. 85:646–651. 2015. View Article : Google Scholar : PubMed/NCBI
17	Oosten AW, Oldenmenger WH, Mathijssen RH and van der Rijt CC: A systematic review of prospective studies reporting adverse events of commonly used opioids for Cancer-Related Pain: A call for the use of standardized outcome measures. J Pain. 16:935–946. 2015. View Article : Google Scholar : PubMed/NCBI
18	Li MC, Yu JH, Yu SS, Chi YY and Xiang YB: MicroRNA-873 Inhibits Morphine-Induced Macrophage Apoptosis by Elevating A20 Expression. Pain Med. 16:1993–1999. 2015. View Article : Google Scholar : PubMed/NCBI
19	He Y, Yang C, Kirkmire CM and Wang ZJ: Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor. J Neurosci. 30:10251–10258. 2010. View Article : Google Scholar : PubMed/NCBI
20	Peng Y, Liu YM, Li LC, Wang LL and Wu XL: MicroRNA-338 inhibits growth, invasion and metastasis of gastric cancer by targeting NRP1 expression. PLoS One. 9:e944222014. View Article : Google Scholar : PubMed/NCBI
21	Guo B, Liu L, Yao J, Ma R, Chang D, Li Z, Song T and Huang C: miR-338-3p suppresses gastric cancer progression through a PTEN-AKT axis by targeting P-REX2a. Mol Cancer Res. 12:313–321. 2014. View Article : Google Scholar : PubMed/NCBI
22	Wood MM and Cousins MJ: Iatrogenic neurotoxicity in cancer patients. Pain. 39:1–3. 1989. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(t)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar
24	Rogler CE, Levoci L, Ader T, Massimi A, Tchaikovskaya T, Norel R and Rogler LE: MicroRNA-23b cluster microRNAs regulate transforming growth factor-beta/bone morphogenetic protein signaling and liver stem cell differentiation by targeting Smads. Hepatology. 50:575–584. 2009. View Article : Google Scholar : PubMed/NCBI
25	Osnes T, Sandstad O, Skar V, Osnes M and Kierulf P: Total protein in common duct bile measured by acetonitrile precipitation and a micro bicinchoninic acid (BCA) method. Scand J Clin Lad Invest. 53:757–763. 1993. View Article : Google Scholar
26	Li P, Chen X, Su L, Li C, Zhi Q, Yu B, Sheng H, Wang J, Feng R, Cai Q, et al: Epigenentic silencing of miR-338-3p contributed to tumorigenicity in gastric cancer by targeting SSX2IP. PLoS One. 8:e667822013. View Article : Google Scholar
27	Chen X, Pan M, Han L, Lu H, Hao X and Dong Q: miR-338-3p suppresses neuroblastoma proliferation, invasion and migration through targeting PREX2a. FEBS Lett. 587:3729–3737. 2013. View Article : Google Scholar : PubMed/NCBI
28	Gunes S, Yegin Z, Sullu Y, Buyukalpelli R and Bagci H: SOX4 expression levels in urothelial bladder carcinoma. Pathol Res Pract. 207:423–427. 2011. View Article : Google Scholar : PubMed/NCBI
29	Zhou Y, Wang X, Huang Y, Chen Y, Zhao G, Yao Q, Jin C, Huang Y, Liu X and Li G: Down-regulated SOX4 expression suppresses cell proliferation, metastasis and induces apoptosis in Xuanwei female lung cancer patients. J Cell Biochem. 116:1007–1018. 2015. View Article : Google Scholar : PubMed/NCBI
30	Jang SM, Kang EJ, Kim JW, Kim CH, An JH and Choi KH: Transcription factor Sox4 is required for PUMA-mediated apoptosis induced by histone deacetylase inhibitor, TSA. Biochem Biophys Res Commun. 438:445–451. 2013. View Article : Google Scholar : PubMed/NCBI
31	Liu LW, Lu J, Wang XH, Fu SK, Li Q and Lin FQ: Neuronal apoptosis in morphine addiction and its molecular mechanism. Int J Clin Exp Med. 6:540–545. 2013.PubMed/NCBI
32	Li MD and van der Vaart AD: MicroRNAs in addiction: Adaptation's middlemen? Mol Psychiatry. 16:1159–1168. 2011. View Article : Google Scholar : PubMed/NCBI
33	Dreyer JL: New insights into the roles of microRNAs in drug addiction and neuroplasticity. Genome Med. 2:922010. View Article : Google Scholar
34	Hollander JA, Im HI, Amelio AL, Kocerha J, Bali P, Lu Q, Willoughby D, Wahlestedt C, Conkright MD and Kenny PJ: Striatal microRNA controls cocaine intake through CREB signalling. Nature. 466:197–202. 2010. View Article : Google Scholar : PubMed/NCBI
35	Rodríguez RE: Morphine and microRNA Activity: Is There a Relation with Addiction? Front Genet. 3:2232012. View Article : Google Scholar : PubMed/NCBI